Stocks to buy today: Mirae Asset Sharekhan sees up to 40% upside in Bajaj Finserv

Main brokerage agency Investec has maintained a ‘Purchase’ score on Medplus Well being Companies, highlighting its strong enlargement plans and promising progress within the generics section.

Mirae Asset Sharekhan has issued a ‘Purchase’ score on Bajaj Finserv, citing its bold long-term technique and give attention to leveraging AI for worthwhile progress.

In the meantime, Hem Securities has really useful a ‘Purchase’ on Parag Milk, pushed by its sturdy earnings progress, strong distribution community, and give attention to value-added merchandise.

We’ve got collated a listing of suggestions from high brokerage companies, sourced from ETNow and different platforms:

Investec on Medplus Well being Companies: Purchase | Goal: Rs 940 | LTP: Rs 844 | Upside: 11%

Investec has maintained a “Purchase” score on Medplus Well being Companies with a goal value of Rs 940, indicating an upside potential of 11% from the present market value of Rs 844.The corporate has outlined an bold progress plan so as to add 600 new shops by FY26, reflecting its dedication to increasing its retail footprint.

Medplus can also be seeing sturdy adoption of generic medicines, significantly amongst prospects with continual situations, which is driving its generics enterprise.

Moreover, the corporate is bringing again its retailer franchise enterprise mannequin as a part of its progress technique.

On the diagnostic entrance, the corporate’s pilot venture in Hyderabad has turned worthwhile, showcasing its potential on this house. Nevertheless, it at present has no plans to develop its diagnostic enterprise additional.

Mirae Asset Sharekhan on Bajaj Finserv: Purchase | Goal: Rs 2,350 | LTP: Rs 1,679 | Upside: 39%

Mirae Asset Sharekhan has issued a “Purchase” score on Bajaj Finserv, setting a goal value of Rs 2,350, which means a big upside potential of 39% from the present market value of Rs 1,679.

Bajaj Finserv unveiled its new long-term technique for FY25-29, figuring out new megatrends throughout enterprise traces and planning to leverage AI capabilities to enhance processes, predict buyer wants, and develop quicker.

On the similar time, the main target stays on capital effectivity, worthwhile progress, and wholesome RoEs. The healthcare and AMC companies are anticipated to interrupt even within the subsequent 3-5 years.

The corporate has guided for a 20-22% CAGR in whole revenue to Rs 3 lakh crore, 18-22% progress in PAT to Rs 20,000 crore, and 17-18% progress in its buyer franchise to twenty crore by FY 2029E.

The brokerage agency has maintained a “Purchase” score with an unchanged SOTP-based PT of Rs 2,350. The group is well-positioned to seize the structural progress story throughout the monetary panorama (lending, investing, and defending) in India over the medium to long run.

Hem Securities on Parag Milk: Purchase | Goal: Rs 255 | LTP: Rs 207 | Upside: 23%

Hem Securities has given a “Purchase” suggestion on Parag Milk with a goal value of Rs 255, suggesting an upside potential of 23% from the present market value of Rs 207.

Parag Meals’ earnings grew at a CAGR of ~16% over FY19-23. Going ahead, we’re constructive on the corporate’s future progress prospects, primarily pushed by its strong distribution community, sturdy model fairness, and steady efforts to develop into newer classes.

The corporate goals to additional improve its product combine by specializing in margin-accretive, value-added merchandise and new-age companies, together with the fixed scaling-up of recent launches.

With a robust progress outlook, Hem Securities has initiated a “Purchase” score on the inventory and values it at 19.2x FY26 EPS to reach on the goal of Rs 255.

(Disclaimer: Suggestions, strategies, views, and opinions given by consultants are their very own. These don’t characterize the views of the Financial Instances)